Crescent Biopharma (C68.F) Q2 2025 Earnings

14MayConfirmed
Q2 2025
-4.47
-4.27
-4.06
-3.86

Details

Expected EPS
-4.46905
Actual EPS
-3.8626446055000003
Surprise EPS
0.61
Surprise Percent
+13.57%

Description

Crescent Biopharma (C68.F) has reported earnings of -3.8626446055000003 per share for Q2 2025.

0 Comments

Share your thoughts